Skip to main content

Want a detailed portfolio tracker?

Arcutis Biotherapeutics (ARQT) P/E (2020 - 2026)

Arcutis Biotherapeutics (ARQT) P/E from Mar 31, 2020 to Jul 21, 2026. The TTM Arcutis Biotherapeutics (ARQT) P/E is -1.40K. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Arcutis Biotherapeutics (ARQT)

YearP/EChange
2026-1.40K+574.36%
2025-206.98+1686.28%
2024-11.59+681.90%
2023-1.48-71.23%
2022-5.15-48.88%
2021-10.08-37.63%
2020-16.16N/A

Comparison Arcutis Biotherapeutics (ARQT) P/E with competitors

Arcutis Biotherapeutics (ARQT) P/E is -1395.81.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-100.01%
FGENFibroGen Inc0.24-100.02%
CHRSCoherus Biosciences Inc0.85-100.06%
FBIOFortress Biotech Inc0.95-100.07%
ORMPOramed Pharmaceuticals Inc1.50-100.11%
AGENAgenus Inc3.01-100.22%
INVAInnoviva Inc3.15-100.23%
VXRTVaxart Inc3.55-100.25%
CRMDCorMedix Inc3.63-100.26%
CVACCureVac N.V.4.45-100.32%
GLPGGalapagos NV4.86-100.35%
SRPTSarepta Therapeutics Inc4.88-100.35%
ABEOAbeona Therapeutics Inc5.39-100.39%
ABUSArbutus Biopharma Corp5.60-100.40%
ZVRAZevra Therapeutics Inc5.89-100.42%
SPROSpero Therapeutics Inc6.23-100.45%
CGENCompugen Ltd6.31-100.45%
RIGLRigel Pharmaceuticals6.87-100.49%
SLXNSilexion Therapeutics Corp7.30-100.52%
OMEROmeros Corporation9.26-100.66%
AUPHAurinia Pharmaceuticals Inc9.58-100.69%
PLXProtalix BioTherapeutics Inc10.89-100.78%
ACADAcadia Pharmaceuticals Inc11.73-100.84%
TBPHTheravance Biopharma Inc12.26-100.88%
ADMAAdma Biologics Inc12.42-100.89%
HRMYHarmony Biosciences Holdings Inc13.82-100.99%
SABSSAB Biotherapeutics Inc14.14-101.01%
NAGENiagen Bioscience Inc14.82-101.06%
INCYIncyte Corp15.82-101.13%
REGNRegeneron Pharmaceuticals Inc15.86-101.14%
PBYIPuma Biotechnology Inc17.32-101.24%
CPRXCatalyst Pharmaceuticals Inc17.44-101.25%
EXELExelixis Inc17.54-101.26%
TGTXTG Therapeutics Inc18.97-101.36%
MDXGMimedx Group Inc20.55-101.47%
XOMAXOMA Royalty Corp22.87-101.64%
ARGXArgen X SE24.30-101.74%
CTMXCytomX Therapeutics Inc24.82-101.78%
XOMAOXOMA Royalty Corp25.34-101.82%
HALOHalozyme Therapeutics Inc25.62-101.84%
XOMAPXOMA Royalty Corp25.67-101.84%
VRTXVertex Pharmaceuticals Inc27.99-102.01%
RPRXRoyalty Pharma plc - Class A28.69-102.06%
SLNOSoleno Therapeutics Inc29.02-102.08%
ASNDAscendis Pharma A/S30.09-102.16%
LGNDLigand Pharmaceuticals Inc - Class B37.91-102.72%
APLSApellis Pharmaceuticals Inc39.02-102.80%
BMRNBiomarin Pharmaceutical Inc42.21-103.02%
KRYSKrystal Biotech Inc45.34-103.25%
ONCBeiGene Ltd69.54-104.98%
PHARPharming Group N.V.75.03-105.38%
TECHBio-Techne Corp101.96-107.30%
VCELVericel Corp109.92-107.88%
ALNYAlnylam Pharmaceuticals Inc117.96-108.45%
GMABGenmab140.29-110.05%
TLXTelix Pharmaceuticals Ltd162.15-111.62%
CORTCorcept Therapeutics Inc212.86-115.25%